Subject: FW: [REPLY REQUESTED] Status Inquiry for Venezuelan Appl. No. 2012-001157; Your Ref.: 17609; Lathrop Ref.: 542695: SA9-096VE
From: Bolet & Terrero <[email-masked]>
To: Dorit Pollak <[email-masked]>, Maria de Fatima Da Silva <[email-masked]>, Ruben Calderon <[email-masked]>
Date: Tue, 16 Jun 2026 14:54:43 +0000

From: Sysa, Natalya V. <[email-masked]>
Sent: Tuesday, June 16, 2026 10:49 AM
To: Luis Henriquez <[email-masked]>; Bolet & Terrero <[email-masked]>
Cc: Boston Patent Distribution <[email-masked]>; Velema, James H. <[email-masked]>; D'Souza, Ph.D., Tanya S. <[email-masked]>; Sampedro, Ph.D., Georgia R. <[email-masked]>
Subject: [REPLY REQUESTED] Status Inquiry for Venezuelan Appl. No. 2012-001157; Your Ref.: 17609; Lathrop Ref.: 542695: SA9-096VE

Re:       Venezuelan Patent Application No. 2012-001157

Title: ANTI-ALPHA BETA TCR ANTIBODIES

Applicant: Genzyme Corporation

Filing Date: September 12, 2012

Sanofi Ref.: 5668-VE-NP

Lathrop Ref.: 542695: SA9-096VE
Your Ref. 17609

Dear Colleagues,

We kindly request that you provide us with a status update for the above-referenced patent application at your earliest convenience.  Please advise us of any outstanding formalities or deadlines requiring our attention.

If you have any questions, please let us know.

Kindly confirm receipt of this email and please advise us accordingly.

Best regards,

Natalya Sysa

On behalf of James H. Velema, Esq. et al
Natalya
Sysa
 
Paralegal
Lathrop GPM LLP
80 South 8th Street, 3100 IDS Center
Minneapolis,
MN
55402‑3796
Direct: 612.632.3356<tel:612.632.3356>
[email-masked]<mailto:[email-masked]>
lathropgpm.com<https://us.content.exclaimer.net/?url=http%3A%2F%2Fwww.lathropgpm.com%2F&tenantid=PK4KpoSPEe6JJQAiSCOAMw&templateid=739b093a43b5ee11bea0002248238075&excomponentid=HHRyCD0yv6Cr8y1dZ6Ox4He0uzS51AiX71mVCSoDaXM&excomponenttype=Link&signature=Koe0DPcyqKPPsXFRwZDAjRzVyB0T4v9VTXG23bLQK36qST_dz4QHB_Wxq0WS0wd9ppYxBWhN2w_t4G3zLbeiX1W9dcaqZltLqv8ZczKmZlfRDK-U30sK9lAucVZGB1NMgvYyrt7AaAkSl1_LcFVIYQdSZy5eJxLT5ucXeQomWTj3EwqOEQvdbNc7XT7e-tY7xaR5AeOHEhckIV6naudbJqf_ghVH_si--Q2HR23xpd1LntG9PsXv7XZ_fgHDdo9S7fdEKhcavWSHMtG5qP7ntatvml25lsKsXyGiJaQJ59YCCZGV20CuopPGymBpdWEVldNGnzAxX0c2C-T6SGA9tg&v=1&imprintMessageId=220552ee-cd4c-4c87-a3ec-0702ad9e5756>
This e-mail (including any attachments) may contain material that (1) is confidential and for the sole use of the intended recipient, and (2) may be protected by the attorney-client privilege, attorney work product doctrine or other legal rules. Any review, reliance or distribution by others or forwarding without express permission is strictly prohibited. If you are not the intended recipient, please contact the sender and delete all copies.